Literature DB >> 36241349

Comparison of endometrial preparation protocols (natural cycle versus hormone replacement cycle) for frozen embryo transfer (COMPETE): a study protocol for a randomised controlled trial.

Xitong Liu1, Wen Wen1, Tao Wang1, Ting Sun1, Ting Wang1, Na Zhang1, Dan Pan1, He Cai1, Jinlin Xie1, Xiaojuan Liu1, Zan Shi1, Rui Wang1, Xiaofang Li1, Na Lu1, Rong Pan1, Li Tian1, Bin Meng1, Haiyan Bai1, Hanying Zhou1, Pengfei Qu2, Doudou Zhao1, Ben W Mol3,4, Wentao Li4, Juanzi Shi5.   

Abstract

INTRODUCTION: Natural cycle (NC) and hormone replacement treatment (HT) are frequently used endometrial preparation protocols prior to frozen-thawed embryo transfer in ovulatory women. It is not clear which protocol results in a higher live birth rate. It has been suggested that there is an increased risk in maternal and perinatal morbidity following HT protocol due to the lack of corpus luteum. The objective of this trial is to compare the clinical outcomes of NC and HT protocols in frozen embryo transfer. METHODS AND ANALYSIS: COMPETE is an open-label, single-centre, randomised controlled trial targeting to recruit 888 women, with 444 women each in two arms (1:1 treatment ratio). Women undergoing in vitro fertilisation scheduled for a frozen embryo transfer and have a regular menstrual cycle are eligible. Exclusion criteria include ovulation disorders and intrauterine adhesions. The primary outcome is live birth resulting from the first frozen embryo transfer after randomisation. Secondary outcomes include biochemical pregnancy, clinical pregnancy, multiple pregnancy, ongoing pregnancy, miscarriage, endometrial thickness, cycle cancellation, gestational diabetes mellitus, hypertensive disorders of pregnancy, antepartum haemorrhage, preterm birth, birth weight, large for gestational age, congenital anomaly and perinatal mortality. The data analysis will be following the intention-to-treat principle. ETHICS AND DISSEMINATION: This study has been approved by the Institutional Review Board of Northwest women's and children's hospital (2020008). Written informed consent will be obtained from each participant before randomisation. The results of the trial will be presented via publications. TRIAL REGISTRATION NUMBER: ChiCTR2000040640. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  GYNAECOLOGY; Reproductive medicine; Subfertility

Mesh:

Substances:

Year:  2022        PMID: 36241349      PMCID: PMC9577921          DOI: 10.1136/bmjopen-2022-063981

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   3.006


  22 in total

Review 1.  Embryo implantation.

Authors:  D D Carson; I Bagchi; S K Dey; A C Enders; A T Fazleabas; B A Lessey; K Yoshinaga
Journal:  Dev Biol       Date:  2000-07-15       Impact factor: 3.582

2.  Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation.

Authors:  Wen-ge Ma; Haengseok Song; Sanjoy K Das; Bibhash C Paria; Sudhansu K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 3.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  Int J Surg       Date:  2011-10-12       Impact factor: 6.071

Review 4.  Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support.

Authors:  Robert F Casper; Elena H Yanushpolsky
Journal:  Fertil Steril       Date:  2016-01-25       Impact factor: 7.329

5.  Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET.

Authors:  Louise Laub Asserhøj; Anne Lærke Spangmose; Anna-Karina Aaris Henningsen; Tine Dalsgaard Clausen; Søren Ziebe; Rikke Beck Jensen; Anja Pinborg
Journal:  Fertil Steril       Date:  2021-01-16       Impact factor: 7.329

6.  Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial.

Authors:  A Nyboe Andersen; B Popovic-Todorovic; K T Schmidt; A Loft; A Lindhard; A Højgaard; S Ziebe; F Hald; B Hauge; B Toft
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

7.  Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial.

Authors:  Tahereh Madani; Fariba Ramezanali; Azar Yahyaei; Fatemeh Hasani; Narges Bagheri Lankarani; Ladan Mohammadi Yeganeh
Journal:  Arch Gynecol Obstet       Date:  2019-02-01       Impact factor: 2.344

8.  Natural cycle frozen-thawed embryo transfer in young women with regular menstrual cycles increases the live-birth rates compared with hormone replacement treatment: a retrospective cohort study.

Authors:  Xitong Liu; Wenhao Shi; Juanzi Shi
Journal:  Fertil Steril       Date:  2020-03-05       Impact factor: 7.329

Review 9.  Cycle regimens for frozen-thawed embryo transfer.

Authors:  Tarek Ghobara; Tarek A Gelbaya; Reuben Olugbenga Ayeleke
Journal:  Cochrane Database Syst Rev       Date:  2017-07-05

10.  Pretreatment with a GnRH agonist and hormone replacement treatment protocol could not improve live birth rate for PCOS women undergoing frozen-thawed embryo transfer cycles.

Authors:  Xitong Liu; Juanzi Shi; Haiyan Bai; Wen Wen
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-18       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.